Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

JAK inhibitors show promise for treating various skin diseases.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

New medications could improve treatment for severe alopecia areata in Australia.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Four natural compounds were found to promote hair growth effectively.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.